Background It is believed that genetic factors play a role in the development and severity of neural injury among people with distal symmetrical polyneuropathy (DSP), because some genes are involved ...

The clinical presentation of peripheral neuropathy resulting from nucleoside analogue treatment is similar to HIV-associated distal symmetrical polyneuropathy. The main differences are: [2] ...

In all, they pooled the results of 77 eligible studies, involving 10,962 participants from 28 countries, all of whom had peripheral neuropathy that was associated with cancer drug treatment.

Gluten neuropathy may result in symptoms such as numbness, tingling, or even sensations of burning and pain. People with peripheral neuropathy suffer from those types of sensations on a regular basis.

Polyneuropathy occurs when multiple peripheral nerves become damaged. Symptoms include problems with sensation, coordination, or other body functions. Polyneuropathy is also known as peripheral ...

Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...

Background: About one third of patients with chronic polyneuropathy have no obvious underlying etiology and are classified as having idiopathic polyneuropathy. The lack of knowledge about ...

Chronic and severe vasculitis leads to axonal loss in multiple areas of a single nerve with eventual involvement of multiple nerves mimicking a distal symmetric polyneuropathy. In the initial phases ...

In many patients who present with new-onset distal symmetric polyneuropathy (DSP), an underlying cause is not initially evident. Clinicians certainly should consider overt diabetes, but whether ...